Found 544 hits.
| 384. | Sabag, D. A.*, Matanes, L.*, Bejar, J., Sheffer, H., Barzilai, A., Church, M. K., Toubi, E., Maurer, M., and Vadasz, Z.+: Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria. Clin. Exp. Allergy 2020: 50; 799-804. IF: 5.02 |
o.384
| 345 | Krause, K., Sabat, R., Witte-Händel, E., Schulze, A., Puhl, V., Maurer, M., and Wolk, K.+: Association of CCL2 with systematic inflammation in Schnitzler syndrome. Br. J. Dermatol. 2019: 180; 859-868. IF: TBD (IF 2018: 6.71) |
| 271 | Krause, K., Tsianakas, A., Wagner, N., Fischer, J., Weller, K., Metz, M., Church, M. K., and Maurer, M.:Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study. J. Allergy Clin. Immunol. 2017: 139; 1311-1320. IF: 13.26 |
| 144 | Konstantinou, G. N., Asero, R., Ferrer, M., Knol, E. F., Maurer, M. Raap, U., Schmid-Grendelmeier, P., Skol, P. S., and Grattan, C. E. H.+: EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013: 68; 27-36. IF: 5.99 |
| 265 | Weller, K.+, Maurer, M. Fridman, M., Supina, D., Schranz, J., and Magerl, M.: Health-related quality of life in hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. Allergy Asthma Proc. 2017: 38; 143-151. IF: 2.21 |
| 262 | Weller, K.+, Magerl, M., Peveling-Oberhag, A., Martus, P., Staubach, P., and Maurer, M.: The angioedema quality of life questionnaire (AE-QoL) – assessment of sensitivity to change and minimal clinically important difference. Allergy 2016: 71; 1203-1209. IF: 7.36 |
| 416. | Matanis, L.*, Eiza, N.*, Sabag, A., Bejar, J., Giménez-Arnau, A. M., Maurer, M., and Vadasz, Z.+: The expression of IL-17, in chronic spontaneous urticaria is linked to semaphorin5A. Biomolecules 2021: 11; 373. IF: 6.06 |
o.416
| 155 | Młynek, A., Vieira dos Santos, R., Ardelean, E., Weller, K., Magerl, M., Church, M. K., and Maurer, M.+: A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism. Clin. Exp. Dermatol. 2013: 38; 360-366. IF: 1.23 |
o.155
| 235 | Inami, A., Matsuda, R., Grobosch, T., Komamura, H., Takeda, K., Yamada, Y., Miyake, M., Hiraoka, K., Maurer, M. Yanai, K., and Tashiro, M.+: A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers. Hum. Psychopharmacol. Clin. Exp. 2016: 31; 167-177. IF: 2.21 |
| 142 | Krause, K., Grattan, C. E., Bindslev-Jensen, C., Gattorno, M., Kallinich, T., de Koning, H. D., Lachmann, H. J., Lipsker, D., Navarini, A. A., Simon, A., Traidl-Hoffmann, C., and Maurer, M.+: How not to miss autoinflammatory diseases masquerading as urticaria. Allergy 2012: 67; 1465-1474. IF: 5.88 |
o.142